Luliconazole clinical trials
Luliconazole is named as an intervention in 2 current clinical trials in our USA and Egypt registers. 1 is recruiting patients now. The most common phase is Phase 2. The sponsor with the most trials is SATO Pharmaceutical Co., Ltd (1). The most-studied condition is Onychomycosis of Toenails.
Where Luliconazole is approved
All regulators →Of the three regulators tracked here, the first to approve Luliconazole was the US, on 14 Nov 2013.
From the regulators' own registers: FDA Drugs@FDA, the EMA medicines list and Health Canada's Notice of Compliance database. Dates are the first listed approval of a product containing only this substance; combination products and nationally authorised EU medicines are not counted.
Luliconazole patents and exclusivity
Expiry tracker →Protections still running for marketed products containing Luliconazole, as listed by the regulators. Expired patents and exclusivities, and discontinued products, are not shown.
- 4 listed patents; the last listed expires 28 Apr 2034 (US 8980931).
- Latest patent on the drug substance itself: 6 Sep 2033 (US 9012484).
Reproduced from the FDA Orange Book and Purple Book (checked 8 Nov 2026) and the European Commission's Union Register of medicinal products (CC BY 4.0; the EU expiry date is calculated exactly as the Commission's register displays it). Listed patents and dates are as submitted to or published by the regulator and may not reflect litigation, invalidation, settlements, lapsed fees or later extensions. This is not legal advice or a freedom-to-operate opinion, and it does not say when a generic or biosimilar will launch.
What health systems spend on Luliconazole
All medicines →From NHSBSA Prescription Cost Analysis (Open Government Licence v3.0) and CMS State Drug Utilization Data. Both are gross amounts: neither system publishes its discounts or rebates per drug. Products combining several substances are not counted here.
Patient leaflets for Luliconazole
The package leaflet is the official guide for patients that comes with every medicine. These links go to the regulators that publish it.
- UKUnited Kingdom: Search MHRA ProductsPatient information leaflets and SmPCs for UK-licensed products.
- USUnited States: Search DailyMedFDA-approved labels, including patient and medication guides.
Leaflets differ between brands and countries; always read the one that comes with your own medicine. This is regulatory information, not medical advice.
Trials by status
Trials by phase
Clinical trials of Luliconazole
2 trials| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
Topical Lactoferrin and Luliconazole, Alone or in Combination, for Tinea Corporis
NCT07937020 · ClinicalTrials.gov ↗ · Tinea Corporis
|
Not applicable | Recruiting | Kafrelsheikh University | Egypt |
|
Safety and Efficacy Study of SKX-16 in Participants With Mild to Moderate Distal Subungual Onychomycosis
NCT07929844 · ClinicalTrials.gov ↗ · Onychomycosis of Toenails
|
Phase 2 | Not yet open | SATO Pharmaceutical Co., Ltd | USA |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
Conditions studied with Luliconazole
2 conditionsSponsors
lead sponsor per trial| Lead sponsor | Trials |
|---|---|
| SATO Pharmaceutical Co., Ltd | 1 |
| Kafrelsheikh University | 1 |
By country register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in USA | 1 | 0 |
| Clinical trials in Egypt | 1 | 1 |
A trial with sites in more than one country appears in each of those registers.
Related compounds
Questions about Luliconazole trials
How many clinical trials are testing Luliconazole?
2 current trials in our USA and Egypt registers name Luliconazole (also registered as SKX-16) as a drug or biological intervention, as of the registry sync on 14 November 2026. Completed and withdrawn studies are not counted.
Are Luliconazole trials recruiting patients?
Yes. 1 of the 2 trials is recruiting: 1 with sites in Egypt. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Who sponsors Luliconazole clinical trials?
SATO Pharmaceutical Co., Ltd (1) and Kafrelsheikh University (1). The number in brackets is how many trials each organisation leads.
Where does this information come from?
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Luliconazole works or whether it is effective, and it is not medical advice.
How this page is built
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Luliconazole works or whether it is effective. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, intervention names and synonyms, phase, overall status, lead sponsor and conditions for every trial on this page
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Luliconazole (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 14 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.